Literature DB >> 30962399

The Rate of CD4 T Cell Entry into the Lungs during Mycobacterium tuberculosis Infection Is Determined by Partial and Opposing Effects of Multiple Chemokine Receptors.

Stella G Hoft1,2, Michelle A Sallin1,3, Keith D Kauffman1, Shunsuke Sakai1, Vitaly V Ganusov4, Daniel L Barber5.   

Abstract

The specific chemokine receptors utilized by Th1 cells to migrate into the lung during Mycobacterium tuberculosis infection are unknown. We previously showed in mice that CXCR3+ Th1 cells enter the lung parenchyma and suppress M. tuberculosis growth, while CX3CR1+ KLRG1+ Th1 cells accumulate in the lung vasculature and are nonprotective. Here we quantify the contributions of these chemokine receptors to the migration and entry rate of Th1 cells into M. tuberculosis-infected lungs using competitive adoptive transfer migration assays and mathematical modeling. We found that in 8.6 h half of M. tuberculosis-specific CD4 T cells migrate from the blood to the lung parenchyma. CXCR3 deficiency decreases the average rate of Th1 cell entry into the lung parenchyma by half, while CX3CR1 deficiency doubles it. KLRG1 blockade has no effect on Th1 cell lung migration. CCR2, CXCR5, and, to a lesser degree, CCR5 and CXCR6 also promote the entry of Th1 cells into the lungs of infected mice. Moreover, blockade of G-protein-coupled receptors with pertussis toxin treatment prior to transfer only partially inhibits T cell migration into the lungs. Thus, the fraction of Th1 cell input into the lungs during M. tuberculosis infection that is regulated by chemokine receptors likely reflects the cumulative effects of multiple chemokine receptors that mostly promote but that can also inhibit entry into the parenchyma.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  CD4 T cells; chemokine receptors; tuberculosis

Mesh:

Substances:

Year:  2019        PMID: 30962399      PMCID: PMC6529656          DOI: 10.1128/IAI.00841-18

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Killer cell lectin-like receptor G1 deficiency significantly enhances survival after Mycobacterium tuberculosis infection.

Authors:  Joshua C Cyktor; Bridget Carruthers; Paul Stromberg; Emilio Flaño; Hanspeter Pircher; Joanne Turner
Journal:  Infect Immun       Date:  2013-01-22       Impact factor: 3.441

2.  Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation.

Authors:  Y Pan; C Lloyd; H Zhou; S Dolich; J Deeds; J A Gonzalo; J Vath; M Gosselin; J Ma; B Dussault; E Woolf; G Alperin; J Culpepper; J C Gutierrez-Ramos; D Gearing
Journal:  Nature       Date:  1997-06-05       Impact factor: 49.962

3.  Cutting edge: identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1.

Authors:  Carsten Gründemann; Monika Bauer; Oliver Schweier; Nanette von Oppen; Ute Lässing; Philippe Saudan; Karl-Friedrich Becker; Klaus Karp; Thomas Hanke; Martin F Bachmann; Hanspeter Pircher
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

4.  Th1 Differentiation Drives the Accumulation of Intravascular, Non-protective CD4 T Cells during Tuberculosis.

Authors:  Michelle A Sallin; Shunsuke Sakai; Keith D Kauffman; Howard A Young; Jinfang Zhu; Daniel L Barber
Journal:  Cell Rep       Date:  2017-03-28       Impact factor: 9.423

5.  CCR2-dependent trafficking of F4/80dim macrophages and CD11cdim/intermediate dendritic cells is crucial for T cell recruitment to lungs infected with Mycobacterium tuberculosis.

Authors:  Wendy Peters; Jason G Cyster; Matthias Mack; Detlef Schlöndorff; Andrea J Wolf; Joel D Ernst; Israel F Charo
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

6.  Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma-homing CD4 T cells.

Authors:  Shunsuke Sakai; Keith D Kauffman; Jason M Schenkel; Cortez C McBerry; Katrin D Mayer-Barber; David Masopust; Daniel L Barber
Journal:  J Immunol       Date:  2014-03-03       Impact factor: 5.422

7.  Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites.

Authors:  Brahma V Kumar; Wenji Ma; Michelle Miron; Tomer Granot; Rebecca S Guyer; Dustin J Carpenter; Takashi Senda; Xiaoyun Sun; Siu-Hong Ho; Harvey Lerner; Amy L Friedman; Yufeng Shen; Donna L Farber
Journal:  Cell Rep       Date:  2017-09-19       Impact factor: 9.995

8.  Defective positioning in granulomas but not lung-homing limits CD4 T-cell interactions with Mycobacterium tuberculosis-infected macrophages in rhesus macaques.

Authors:  K D Kauffman; M A Sallin; S Sakai; O Kamenyeva; J Kabat; D Weiner; M Sutphin; D Schimel; L Via; C E Barry; T Wilder-Kofie; I Moore; R Moore; D L Barber
Journal:  Mucosal Immunol       Date:  2017-07-26       Impact factor: 7.313

9.  Strong Inference in Mathematical Modeling: A Method for Robust Science in the Twenty-First Century.

Authors:  Vitaly V Ganusov
Journal:  Front Microbiol       Date:  2016-07-22       Impact factor: 5.640

10.  Quantifying Limits on Replication, Death, and Quiescence of Mycobacterium tuberculosis in Mice.

Authors:  Margaret M McDaniel; Nitin Krishna; Winode G Handagama; Shigetoshi Eda; Vitaly V Ganusov
Journal:  Front Microbiol       Date:  2016-06-14       Impact factor: 5.640

View more
  12 in total

1.  Designing of a Chimeric Vaccine Using EIS (Rv2416c) Protein Against Mycobacterium tuberculosis H37Rv: an Immunoinformatics Approach.

Authors:  R Logesh; V Lavanya; Shazia Jamal; Neesar Ahmed
Journal:  Appl Biochem Biotechnol       Date:  2021-11-24       Impact factor: 2.926

2.  Mathematical Modeling to Guide Experimental Design: T Cell Clustering as a Case Study.

Authors:  Harshana Rajakaruna; Vitaly V Ganusov
Journal:  Bull Math Biol       Date:  2022-08-17       Impact factor: 3.871

3.  A Blunted GPR183/Oxysterol Axis During Dysglycemia Results in Delayed Recruitment of Macrophages to the Lung During Mycobacterium tuberculosis Infection.

Authors:  Minh Dao Ngo; Stacey Bartlett; Helle Bielefeldt-Ohmann; Cheng Xiang Foo; Roma Sinha; Buddhika Jayakody Arachchige; Sarah Reed; Thomas Mandrup-Poulsen; Mette Marie Rosenkilde; Katharina Ronacher
Journal:  J Infect Dis       Date:  2022-06-15       Impact factor: 7.759

4.  In vivo antigen expression regulates CD4 T cell differentiation and vaccine efficacy against Mycobacterium tuberculosis infection.

Authors:  Helena Strand Clemmensen; Jean-Yves Dube; Fiona McIntosh; Ida Rosenkrands; Gregers Jungersen; Claus Aagaard; Peter Andersen; Marcel A Behr; Rasmus Mortensen
Journal:  bioRxiv       Date:  2021-02-03

Review 5.  Legend of the Sentinels: Development of Lung Resident Memory T Cells and Their Roles in Diseases.

Authors:  Youkun Qian; Yicheng Zhu; Yangyang Li; Bin Li
Journal:  Front Immunol       Date:  2021-02-02       Impact factor: 7.561

6.  Leukocytes from Patients with Drug-Sensitive and Multidrug-Resistant Tuberculosis Exhibit Distinctive Profiles of Chemokine Receptor Expression and Migration Capacity.

Authors:  Ranferi Ocaña-Guzmán; Norma A Téllez-Navarrete; Lucero A Ramón-Luing; Iliana Herrera; Marlon De Ita; José-Luis Carrillo-Alduenda; José Alberto Choreño-Parra; Karen Medina-Quero; Joaquín Zúñiga; Leslie Chávez-Galán
Journal:  J Immunol Res       Date:  2021-04-21       Impact factor: 4.818

7.  A recombinant bovine adenoviral mucosal vaccine expressing mycobacterial antigen-85B generates robust protection against tuberculosis in mice.

Authors:  Arshad Khan; Ekramy E Sayedahmed; Vipul K Singh; Abhishek Mishra; Stephanie Dorta-Estremera; Sita Nookala; David H Canaday; Min Chen; Jin Wang; K Jagannadha Sastry; Suresh K Mittal; Chinnaswamy Jagannath
Journal:  Cell Rep Med       Date:  2021-08-17

8.  Early IL-10 promotes vasculature-associated CD4+ T cells unable to control Mycobacterium tuberculosis infection.

Authors:  Catarina M Ferreira; Ana Margarida Barbosa; Palmira Barreira-Silva; Ricardo Silvestre; Cristina Cunha; Agostinho Carvalho; Fernando Rodrigues; Margarida Correia-Neves; António G Castro; Egídio Torrado
Journal:  JCI Insight       Date:  2021-11-08

9.  Self-adjuvanting nanovaccines boost lung-resident CD4+ T cell immune responses in BCG-primed mice.

Authors:  Megan A Files; Kubra F Naqvi; Tais B Saito; Tara M Clover; Jai S Rudra; Janice J Endsley
Journal:  NPJ Vaccines       Date:  2022-04-26       Impact factor: 9.399

10.  Rescuing ESAT-6 Specific CD4 T Cells From Terminal Differentiation Is Critical for Long-Term Control of Murine Mtb Infection.

Authors:  Helena Strand Clemmensen; Niels Peter Hell Knudsen; Rolf Billeskov; Ida Rosenkrands; Gregers Jungersen; Claus Aagaard; Peter Andersen; Rasmus Mortensen
Journal:  Front Immunol       Date:  2020-11-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.